#CCR26 REMAP-CAP has been presented at our meeting a few times, and its always a pleasure to host the team and their results https://www.remapcap.org/
Today's presentation focusses on antiviral use in the influenza domain: Oseltamivir (5 / 10 days) vs. no antiviral
